ULTIMA GENOMICS
Ultima Genomics is unleashing the power of genomics at scale. Ultima Genomics drives the scale of genomic information to enable unprecedented advances in biology and improvements in human health. The company was founded in 2016 and is based in Newark, California.
ULTIMA GENOMICS
Industry:
Biotechnology Health Care Life Science Medical
Founded:
2016-01-01
Address:
Newark, California, United States
Country:
United States
Website Url:
http://www.ultimagenomics.com
Total Employee:
251+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
600 M USD
Technology used in webpage:
Amazon Google Cloud Singapore
Similar Organizations
AUM LifeTech
AUM LifeTech is a Philadelphia based biotechnology company with a revolutionary nucleic acids platform.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
TCR2
TCR2 is a discovery stage pharmaceutical company that developed a unique proprietary TRuCโข platform.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Current Employees Featured
Founder
Investors List
General Atlantic
General Atlantic investment in Venture Round - Ultima Genomics
Playground Global
Playground Global investment in Venture Round - Ultima Genomics
Marius Nacht
Marius Nacht investment in Venture Round - Ultima Genomics
Founders Fund
Founders Fund investment in Venture Round - Ultima Genomics
Khosla Ventures
Khosla Ventures investment in Venture Round - Ultima Genomics
Lightspeed Venture Partners
Lightspeed Venture Partners investment in Venture Round - Ultima Genomics
D1 Capital Partners
D1 Capital Partners investment in Venture Round - Ultima Genomics
aMoon Fund
aMoon Fund investment in Venture Round - Ultima Genomics
Andreessen Horowitz
Andreessen Horowitz investment in Venture Round - Ultima Genomics
Official Site Inspections
http://www.ultimagenomics.com Semrush global rank: 4.92 M Semrush visits lastest month: 1.74 K
- Host name: ec2-13-52-115-166.us-west-1.compute.amazonaws.com
- IP address: 13.52.115.166
- Location: San Jose United States
- Latitude: 37.3388
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95141
More informations about "Ultima Genomics"
About Ultima Genomics | Ultima Genomics, Inc.
At Ultima Genomics, our mission is to continuously drive the scale of genomic information to enable unprecedented advances in biology and improvements in human health. To achieve โฆSee details»
Ultima Genomics - Crunchbase Company Profile
Medical. Ultima Genomics, Inc. [email protected]. Ultima Genomics is unleashing the power of genomics at scale. Ultima Genomics drives the scale of genomic information to enable unprecedented advances in biology and โฆSee details»
Ultima Genomics - LinkedIn
Ultima Genomics is honored to be named the 'Overall Genomics Company of the Year' in the Genomics & CGT category by BioTech Breakthrough, an organization recognizing leaders in life sciences and ...See details»
Gilad Almogy - CEO at Ultima Genomics - The Org
Gilad Almogy founded Ultima Genomics in 2016 with a mission to continuously reduce the cost of sequencing to enable the era of data-driven healthcare, transform biology, and improve human health.See details»
News & Events | Ultima Genomics, Inc.
May 2, 2024 Ultima Genomics, Inc. is revolutionizing DNA sequencing technology with the UG 100 by providing scalability for the $100 genomeSee details»
Ultima Genomics Adds Tenured Strategic and Technology โฆ
Jun 26, 2023 Prior to joining Ultima, Shlomey was heading a more than 1,000-person organization in the fields of Security and Defense within the military, driving high-risk and high โฆSee details»
Ultima Genomics CEO and Key Executive Team | Craft.co
Ultima Genomics's Founder & Chief Executive Officer is Gilad Almogy. Other executives include David Peoples, Chief Financial Officer; Mark Pratt, Chief Technology Officer and 12 others. โฆSee details»
Ultima Genomics Seeks to Deliver the $100 Genome
June 2, 2022. Today Ultima Genomics emerged from stealth mode with a new high-throughput, low-cost sequencing platform that seeks to deliver the $100 genome. Ultimaโs goal is to unleash a new era in genomics-driven research โฆSee details»
Ultima Genomics raises $600 million to lower genome โฆ
Jun 1, 2022 Ultima Genomics, a Newark Calif.-based gene sequencing startup, exited stealth with around $600 million in venture capital funding. Why it matters: Ultima claims it can sequence an entire genome for just $100, which is an โฆSee details»
Ultima Genomics Announces End of Early Access and โฆ
Jan 30, 2024 Ultima Genomics Announces End of Early Access and Upcoming Launch of UG 100โข. January 30, 2024 08:00 AM Eastern Standard Time. FREMONT, Calif.-- ( BUSINESS WIRE )-- Ultima Genomics, Inc ., a ...See details»
Ultima Genomics signs development agreement with Regeneron โฆ
NEWARK, Calif., July 12, 2022 /PRNewswire/ -- Ultima Genomics, Inc. (the Company) has signed an agreement with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) to further advance โฆSee details»
Ultima Genomics Delivers the $100 Genome
May 31, 2022 Media inquiries: [email protected]. NEWARK, California, May 31st, 2022 โ Today Ultima Genomics emerged from stealth mode with a new high-throughput, low โฆSee details»
Set to Join the NGS Race, Ultima Genomics Offers a Peek under โฆ
Oct 10, 2023 Ultima Genomics has been quiet since the June 2022 Advances in Genome Biology and Technology (AGBT) conference, where the company boldly entered the next โฆSee details»
Ultima Genomics and Integrated DNA Technologies to Enable โฆ
Feb 6, 2023 To learn more, visit www.ultimagenomics.com About IDT Integrated DNA Technologies, Inc. ( IDT ) develops, manufactures, and markets nucleic acid products for the โฆSee details»
Labcorp expands Ultima pact to boost genomic diagnostics
Jul 31, 2024 Dive Brief: Labcorp said this week it expanded its collaboration with Ultima Genomics to explore new clinical applications for whole genome sequencing.; The laboratory โฆSee details»
Ultima Genomics signs development agreement with Regeneron โฆ
NEWARK, Calif., July 12, 2022 โ Ultima Genomics, Inc. (the Company) has signed an agreement with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) to further advance Ultima โฆSee details»
Ultima Genomics Collaborates with NVIDIA To Deliver $100 โฆ
NEWARK, Calif., June 6, 2022 /PRNewswire/ -- Ultima Genomics, Inc. today unveiled a broad collaboration with NVIDIA that leverages AI-accelerated analysis across multiple stages of the โฆSee details»
Ultima announces UG 100โข and reveals disruptive cost and โฆ
Feb 26, 2024 Low-cost reagents.One wafer and reagent configuration for $2,000 delivers 6-8 B reads and an expected average read length of 300 base pairs or an output of up to 2.4 Tb per โฆSee details»
Publications & Resources | Ultima Genomics, Inc.
May 31, 2022 Read the latest on our technology and how it's impacting whole genome sequencing to population sequencing to cancer genomicsSee details»